AQQRF.US Aquarius Surgical Technologies Inc
- Market cap
- USD 116K
- P/E
- -
- P/B
- 32.26x
- ROE
- -
- Dividend yield
- -
- Fundamental score
- -
Ratios use the latest price and the current fiscal year annualized from 1 quarter up to Jun 2026.
Is AQQRF.US undervalued?
Graham numberThe Graham number of Aquarius Surgical Technologies Inc cannot be estimated reliably (it needs positive earnings and book value).
Graham number = √(22.5 × EPS × book value per share): the most a defensive investor should pay according to Benjamin Graham. An estimate, not a recommendation to buy or sell. How is it calculated?
Aquarius Surgical Technologies Inc fundamental analysis
No fundamental analysis for Aquarius Surgical Technologies Inc yet.
Aquarius Surgical Technologies Inc stock price
Prices on the chart can differ slightly from the closing prices StockSummer uses for its ratios.
About Aquarius Surgical Technologies Inc
Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada. The company offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, as well as medical and fibre-optic delivery devices. It exports its products to …
Full company profileAquarius Surgical Technologies Inc financial statements
2026 annualized: Fiscal year 2026 is not finished. Income statement and cash flow are annualized from 1 quarter up to Jun 30, 2026, the balance sheet is the latest quarter. Figures change when the annual report is published.
Aquarius Surgical Technologies Inc annual financial statements (CAD; K = thousand, M = million, B = billion, T = trillion)
| Item | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | 2026 | 2026 Anlz |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | |||||||||||
| Revenue | 5.90K | 975K | 393K | 959K | 583K | 328K | 204K | 205K | 91.2K | 91.4K | 71.2K |
| Gross Profit | -39.9K | -380K | 44.2K | 247K | 81.0K | 79.2K | 74.1K | 133K | 47.3K | 49.1K | 37.7K |
| Operating Income | -883K | -1.92M | -1.37M | -1.31M | -793K | -687K | -644K | -459K | -546K | -257K | -207K |
| EBITDA | -834K | -6.90M | -1.24M | -1.18M | -1.34M | -611K | -517K | -430K | -833K | -235K | -215K |
| Net Income | -876K | -6.25M | -1.59M | -1.61M | -1.81M | -859K | -723K | -758K | -1.17M | -652K | -610K |
| EPS | -0.15 | -0.35 | -0.08 | -0.08 | -0.08 | -0.04 | -0.03 | -0.03 | -0.04 | -0.02 | -0.02 |
| Balance Sheet | |||||||||||
| Total Assets | 8.40M | 1.61M | 1.72M | 1.66M | 946K | 895K | 680K | 574K | 1.95M | 1.91M | 1.90M |
| Total Liabilities | 3.10M | 1.48M | 2.18M | 2.35M | 3.34M | 4.11M | 4.53M | 5.18M | 7.72M | 8.34M | 8.48M |
| Shareholders' Equity | 5.02M | 129K | -454K | -689K | -2.39M | -3.21M | -3.85M | -4.61M | -5.77M | -6.42M | -6.58M |
| Cash & Short-term Investments | 1.12M | 163K | 125K | 105K | 146K | 158K | 122K | 107K | 7.56K | 44.5K | 47.7K |
| Total Debt | - | 1.05M | 250K | 2.02M | 810K | 779K | 3.51M | 4.04M | 6.47M | 6.94M | 7.07M |
| Cash Flow | |||||||||||
| Operating Cash Flow | -325K | -1.61M | -1.35M | -951K | -409K | -133K | 38.8K | -253K | -383K | -116K | -53.2K |
| Capital Expenditure | 25.2K | 33.5K | 819K | 123K | 100K | 5.22K | 0.00 | 4.36K | 0.00 | 0.00 | 0.00 |
| Free Cash Flow | -351K | -1.65M | -2.17M | -1.07M | -509K | -138K | 53.0K | -257K | -383K | -116K | -53.2K |
| Ratios | |||||||||||
| ROE | -17.5% | -4,858.2% | - | - | - | - | - | - | - | - | - |
| ROA | -10.4% | -387.8% | -92.0% | -97.1% | -191.3% | -96.0% | -106.4% | -131.9% | -59.9% | -34.1% | -32.0% |
| Net Profit Margin | -14,865.3% | -641.5% | -403.3% | -168.0% | -310.3% | -262.2% | -355.1% | -369.1% | -1,279.8% | -712.7% | -855.7% |
| Debt to Equity | - | 8.12x | - | - | - | - | - | - | - | - | - |
What these items mean
- Revenue
- Total sales of goods and services in the period.
- Gross Profit
- Revenue minus the direct cost of producing what was sold.
- Operating Income
- Profit from the core business after operating expenses.
- EBITDA
- Earnings before interest, taxes, depreciation and amortization.
- Net Income
- Profit left for shareholders after all expenses, interest and taxes.
- EPS
- Net income divided by shares outstanding.
- Total Assets
- Everything the company owns.
- Total Liabilities
- Everything the company owes.
- Shareholders' Equity
- Assets minus liabilities: the book value that belongs to shareholders.
- Cash & Short-term Investments
- Cash and investments that can be turned into cash quickly.
- Total Debt
- Short and long-term borrowings.
- Operating Cash Flow
- Cash generated by the core business.
- Capital Expenditure
- Cash spent on property, plant and equipment.
- Free Cash Flow
- Operating cash flow minus capital expenditure: cash left for dividends, buybacks or debt repayment.
- ROE
- Return on equity: net income divided by shareholders' equity.
- ROA
- Return on assets: net income divided by total assets.
- Net Profit Margin
- Net income as a share of revenue.
- Debt to Equity
- Total debt divided by shareholders' equity.
Aquarius Surgical Technologies Inc dividends
- Dividend yield
- -
- Forward dividend
- -
- Payout ratio
- -
- Ex-dividend date
- -
| Fiscal year | Dividends paid | Per share | Payout ratio |
|---|---|---|---|
| 2026 | - | - | - |
| 2025 | - | - | - |
| 2024 | - | - | - |
| 2023 | - | - | - |
| 2022 | - | - | - |
| 2021 | - | - | - |
| 2020 | USD 250K | 0.01 | - |
| 2019 | USD 500K | 0.03 | - |
| 2018 | - | - | - |
From the cash flow statement: dividends paid in the fiscal year, divided by that year's shares outstanding. Payout ratio = dividends paid / net income.
Last stock split: 1:20 on Jun 22, 2017.
Who owns Aquarius Surgical Technologies Inc
- Insiders 51.40%
- Institutions 0.00%
- Public & others 48.60%
- Shares outstanding 27.6M
- Free float 13.4M
Aquarius Surgical Technologies Inc company profile
- Company name
- Aquarius Surgical Technologies Inc
- Ticker
- AQQRF.US
- ISIN
- CA03842P1009
- Exchange
- USA Stocks
- Sector
- Healthcare
- Industry
- Health Care Equipment & Supplies
- Fiscal year end
- March
- Address
- 89 Scollard Street, Toronto, ON, Canada, M5R 1G4
- Phone
- 902-410-9013
- Website
- aquariussurgical.com
About Aquarius Surgical Technologies Inc
Aquarius Surgical Technologies Inc., through its subsidiary, Surgical Lasers Inc., engages in the development, sale, distribution, and marketing of technologies for use in surgical and other environments in Canada. The company offers integrated laser-based solutions across multiple medical disciplines, including urology, gynecology, ophthalmology, thoracic, ENT, cardiovascular, and neurosurgery, as well as medical and fibre-optic delivery devices. It exports its products to the United States. The company was formerly known as Aquarius Coatings, Inc. and changed its name to Aquarius Surgical Technologies Inc. in March 2017. Aquarius Surgical Technologies Inc. was incorporated in 1986 and is based in Toronto, Canada.
Aquarius Surgical Technologies Inc management
3- Mr. Lorne Stewart MacFarlaneCEO & CFO
- Mr. Brian WagnerVice President of Sales for SLI US Inc.
- Mr. Christopher H. FreemanSecretary